by Raynovich Rod | Aug 15, 2017 | Biopharmaceuticals
Not Much To Report-Vacation Doldrums Momentum Has Eased a Tad Investors Expecting Growth from Large Caps and M&A from Mid-Caps. We are on vacation until August 25 unless big news and volatility breaks. Here is where we are as of August 15: IBB at $309.31 off July...
by Raynovich Rod | Aug 1, 2017 | Biopharmaceuticals
Rayno Large Cap Biopharma Earnings Summary 8/1/17 Biotech Stocks Hit Highs in Mid-July up 18%, 30% on XBI (Click on “urls” below for Company Press Release) All the large cap biopharmaceutical earnings have come in except Regeneron (REGN) which will report...
by Raynovich Rod | Jul 25, 2017 | Biopharmaceuticals
Update-2 7/31 After Close: Biotechs Remain Weak But No Sell Signal As we track the XBI over the past 5 days we are about 3.2% off highs from $82 down to $78.17. Although the XBI has been our top ETF pick since January 2017 we recently put new buys on hold and...
by Raynovich Rod | Jul 19, 2017 | Biopharmaceuticals
Update-1… JY 19…Biotech and Healthcare Stocks Continue to Rally IBB breaks through top to $322.92 up 21.68% YTD; XBI up 1.34% today 35.4% YTD; XLV up 17.6% YTD. Rayno Life Science top winners YTD: ABBV up 18.19%, AMGN up 22.6%, BLUE up 55% YTD, FMI up...
by Raynovich Rod | Jul 13, 2017 | Biopharmaceuticals
Update after close 7/13: Health Care draft bill appears to have stabilized biotech despite opposition. ETFs end in green but XLV is flat. More analysis is coming tomorrow. ========= It’s Vacation Time We are out on vaca until Monday the 17th. Here are some...
by Raynovich Rod | Jul 1, 2017 | 2025 Rayno Biopharmaceuticals Portfolio
Big Biotech Gains for Stocks in First Half Rayno Life Science Picks Top Winners YTD: Foundation Medicine (FMI) up 124.6%, bluebird bio (BLUE) up 70.26%, XBI up 20.9%. Large cap winners since inception: Abbvie (ABBV) and Roche ADR (RHHBY). 6/27 Take some profits on XBI...
by Raynovich Rod | Jun 29, 2017 | Biopharmaceuticals
Tech Wreck Part 2? Or Just Profit Taking. Sector Rotation Away from Large Cap Growth (QQQ) to Value (XLF) Volatility Returns Tech and biotech stocks were hit from sector rotation with the NASDAQ down 2.18 % to and the QQQ down 2% to $136.75 as of mid-day trading. This...
by Raynovich Rod | Jun 27, 2017 | Biopharmaceuticals, Clinical Diagnostics and Tools
Genomics and the Future of Personalized Medicine and Diagnostics Description of Track The opening plenary of the Personalized Medicine & Diagnostics Track will feature J. Craig Venter, Founder, Chairman and Chief Executive Officer of the J. Craig Venter Institute,...
by Raynovich Rod | Jun 26, 2017 | Biopharmaceuticals, Clinical Diagnostics and Tools
Big Data Provides Pathway to Precision Medicine Description of Track Speaker Atul Butte, MD,Ph.D. Director, UCSF Institute for Computational Health Sciences The remarkable ascent of Big Data for example from biomedical imaging, next generation sequencing and adjacent...
by Raynovich Rod | Jun 22, 2017 | Biopharmaceuticals
CAR-T Therapies on Solid Tumors Here is an excellent summary by BIOtechNow Editors on the application of CAR-T (Chimeric Antigen Receptor) T-Cell therapies on solid tumors. Up until now CAR-T shows great promise against blood cancers but challenges remain for solid...
